Zoetis Inc header image

Zoetis Inc

ZTS

Equity

ISIN null / Valor 19276994

New York Stock Exchange, Inc (2026-06-04)
USD 79.52+2.49%

Zoetis Inc
UMushroom community rating:

star star star star star
3.57 5 votes No rating yet
NegativeNeutralPositive

About company

Zoetis Inc. is a global leader in the animal health industry, providing a comprehensive range of products and services that cater to the health needs of animals. With operations spanning over 100 countries, the company's portfolio encompasses a wide array of medicines, vaccines, diagnostics, and technologies designed to support the health and well-being of animals across various sectors, including livestock and companion animals. Zoetis is recognized for its innovative approach in developing solutions that address both common and emerging health challenges faced by animals, thereby contributing significantly to the global animal health sector. The company's commitment to research and development is evident in its robust pipeline, which ensures a continuous introduction of new and improved products to the market, further solidifying its position as a key player in the animal health industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-52.8%1Y
-53.7%3Y
-54.6%5Y

Performance

29.6%1Y
26.6%3Y
26.7%5Y

Volatility

Market cap

33337 M

Market cap (USD)

Daily traded volume (Shares)

7,355,153

Daily traded volume (Shares)

1 day high/low

163.89 / 161.59

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.57

5 votes
Performance:
starstarstarstarstar
3.71
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Noah Juganar
United Kingdom, 23 Oct 2025
star star star star star
Solid fundamentals in financials & competitive advantages
D X
Switzerland, 16 Apr 2025
star star star star star
Langfristige Chance
D X
Switzerland, 29 Mar 2025
star star star star star
Ein Unternehmen, das meiner Meinung nach in einem zukunftsträchtigen Markt vorne mit dabei ist.

EQUITIES OF THE SAME SECTOR

Sanofi SA
Sanofi SA Sanofi SA Valor: 699381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.97%EUR 76.44
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%CHF 324.60
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 20.07
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.09%CHF 83.30
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.77%CHF 4.45
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%USD 43.38
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.47%CHF 137.80
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%USD 20.14
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 1.00
RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.81%EUR 12.40